MAB9630100
Anti- Rituximab (Anti-Idiotype) Antibody, R&D Systems™
Manufacturer: Fischer Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | MAB9630100-Each-of-1 | In Stock | ₹ 49,025.88 |
MAB9630100 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 49,025.88
GST (18%): ₹ 8,824.658
Total Price: ₹ 57,850.538
Antigen
Rituximab
Classification
Monoclonal
Conjugate
Unconjugated
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species
Rabbit
Purification Method
Protein A or G purified from cell culture supernatant
Primary or Secondary
Primary
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype
IgG
Applications
Western Blot, Flow Cytometry, ELISA
Clone
2260A
Dilution
Western Blot 0.5 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, ELISA, Binding Inhibition 2.5 ug/mL
Gene Alias
B lymphocyte antigen CD20, B lymphocyte surface antigen B1, Bp35, CD20, LEU 16, LEU16, Membrane spanning 4 domains subfamily A member 1, MS4A1
Immunogen
Full-length Rituximab
Quantity
100 μg
Test Specificity
Detects Rituximab in Western blots in direct ELISAs. 100% cross-reactivity with Tositumomab and Ibritumomab (95% or higher sequence identity with Rituximab) and no cross-reactivity with Cetuximab, Trastuzumab, Brentuximab, Gemtuzumab, Adalimumab, Solanezumab, Teprotumumab, and Aducanumab is observed.
Target Species
Multi-species
Form
Supernatant
Related Products
Description
- Rituximab Monoclonal specifically detects Rituximab in Multi-Species samples
- It is validated for Western Blot, Flow Cytometry, ELISA, Binding Inhibition.
Compare Similar Items
Show Difference
Antigen: Rituximab
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species: Rabbit
Purification Method: Protein A or G purified from cell culture supernatant
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG
Applications: Western Blot, Flow Cytometry, ELISA
Clone: 2260A
Dilution: Western Blot 0.5 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, ELISA, Binding Inhibition 2.5 ug/mL
Gene Alias: B lymphocyte antigen CD20, B lymphocyte surface antigen B1, Bp35, CD20, LEU 16, LEU16, Membrane spanning 4 domains subfamily A member 1, MS4A1
Immunogen: Full-length Rituximab
Quantity: 100 μg
Test Specificity: Detects Rituximab in Western blots in direct ELISAs. 100% cross-reactivity with Tositumomab and Ibritumomab (95% or higher sequence identity with Rituximab) and no cross-reactivity with Cetuximab, Trastuzumab, Brentuximab, Gemtuzumab, Adalimumab, Solanezumab, Teprotumumab, and Aducanumab is observed.
Target Species: Multi-species
Form: Supernatant
Antigen:
Rituximab
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species:
Rabbit
Purification Method:
Protein A or G purified from cell culture supernatant
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG
Applications:
Western Blot, Flow Cytometry, ELISA
Clone:
2260A
Dilution:
Western Blot 0.5 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, ELISA, Binding Inhibition 2.5 ug/mL
Gene Alias:
B lymphocyte antigen CD20, B lymphocyte surface antigen B1, Bp35, CD20, LEU 16, LEU16, Membrane spanning 4 domains subfamily A member 1, MS4A1
Immunogen:
Full-length Rituximab
Quantity:
100 μg
Test Specificity:
Detects Rituximab in Western blots in direct ELISAs. 100% cross-reactivity with Tositumomab and Ibritumomab (95% or higher sequence identity with Rituximab) and no cross-reactivity with Cetuximab, Trastuzumab, Brentuximab, Gemtuzumab, Adalimumab, Solanezumab, Teprotumumab, and Aducanumab is observed.
Target Species:
Multi-species
Form:
Supernatant
Antigen: Rituximab
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species: Rabbit
Purification Method: Protein A or G purified from cell culture supernatant
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG
Applications: Western Blot, Flow Cytometry, ELISA
Clone: 2260A
Dilution: Western Blot 0.5 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, ELISA, Binding Inhibition 2.5 ug/mL
Gene Alias: B lymphocyte antigen CD20, B lymphocyte surface antigen B1, Bp35, CD20, LEU 16, LEU16, Membrane spanning 4 domains subfamily A member 1, MS4A1
Immunogen: Full-length Rituximab
Quantity: 25 μg
Test Specificity: Detects Rituximab in Western blots in direct ELISAs. 100% cross-reactivity with Tositumomab and Ibritumomab (95% or higher sequence identity with Rituximab) and no cross-reactivity with Cetuximab, Trastuzumab, Brentuximab, Gemtuzumab, Adalimumab, Solanezumab, Teprotumumab, and Aducanumab is observed.
Target Species: Multi-species
Form: Supernatant
Antigen:
Rituximab
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species:
Rabbit
Purification Method:
Protein A or G purified from cell culture supernatant
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG
Applications:
Western Blot, Flow Cytometry, ELISA
Clone:
2260A
Dilution:
Western Blot 0.5 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, ELISA, Binding Inhibition 2.5 ug/mL
Gene Alias:
B lymphocyte antigen CD20, B lymphocyte surface antigen B1, Bp35, CD20, LEU 16, LEU16, Membrane spanning 4 domains subfamily A member 1, MS4A1
Immunogen:
Full-length Rituximab
Quantity:
25 μg
Test Specificity:
Detects Rituximab in Western blots in direct ELISAs. 100% cross-reactivity with Tositumomab and Ibritumomab (95% or higher sequence identity with Rituximab) and no cross-reactivity with Cetuximab, Trastuzumab, Brentuximab, Gemtuzumab, Adalimumab, Solanezumab, Teprotumumab, and Aducanumab is observed.
Target Species:
Multi-species
Form:
Supernatant
Antigen: Teprotumumab
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG2a
Applications: Western Blot, ELISA
Clone: 975505
Dilution: Western Blot 2 ug/mL, ELISA
Gene Alias: __
Immunogen: Full-length Teprotumumab
Quantity: 100 μg
Test Specificity: Detects Teprotumumab in Western blots and direct ELISAs.
Target Species: Multi-species
Form: Supernatant
Antigen:
Teprotumumab
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species:
Mouse
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG2a
Applications:
Western Blot, ELISA
Clone:
975505
Dilution:
Western Blot 2 ug/mL, ELISA
Gene Alias:
__
Immunogen:
Full-length Teprotumumab
Quantity:
100 μg
Test Specificity:
Detects Teprotumumab in Western blots and direct ELISAs.
Target Species:
Multi-species
Form:
Supernatant
Antigen: Teprotumumab
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG2a
Applications: Flow Cytometry
Clone: 975547
Dilution: Flow Cytometry 0.25 ug/10^6 cells, Binding Inhibition 2.5 ug/mL
Gene Alias: __
Immunogen: Full-length Teprotumumab
Quantity: 100 μg
Test Specificity: Detects Teprotumumab in direct ELISAs.
Target Species: Multi-species
Form: Supernatant
Antigen:
Teprotumumab
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species:
Mouse
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG2a
Applications:
Flow Cytometry
Clone:
975547
Dilution:
Flow Cytometry 0.25 ug/10^6 cells, Binding Inhibition 2.5 ug/mL
Gene Alias:
__
Immunogen:
Full-length Teprotumumab
Quantity:
100 μg
Test Specificity:
Detects Teprotumumab in direct ELISAs.
Target Species:
Multi-species
Form:
Supernatant